
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN …
These studies provide the first direct evidence for both the involvement of the FGFR1 V561M mutation and PTEN inactivation in the development of resistance in leukemias overexpressing chimeric FGFR1. These studies also provide a potential strategy to treat leukemias and lymphomas driven by FGFR1 activation that become resistant to FGFR1 inhibitors.
Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR …
There are four identified FGFR receptors, FGFR1, FGFR2, FGFR3, and FGFR4 that bind to a variety of FGFs. Twenty-two different FGFs have also been identified. FGF1 through FGF10 all bind to FGFRs. FGF11 through FGF14 have similar homologies to the other FGFs, but do not bind to FGFRs and have distinct functional differences.
Downregulation of PUMA underlies resistance to FGFR1
2020年10月20日 · Treatment with different tyrosine kinase inhibitors (TKIs) revealed that, in both FGFR1 mutation and Pten deletion-mediated resistance, sustained Akt activation in resistant cells leads to...
Mechanisms of FGFR1 inhibitor resistance involves FGFR1
In FGFR-driven leukemia, the activation mutation V561M within the FGFR1 tyrosine kinase domain, coupled with inactivation of PTEN, led to increased PI3K/AKT activity and acquired resistance to...
PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression in pulmonary
2019年9月3日 · PD-L1, FGFR1, PIK3CA, PTEN, and p16 expression were evaluated by immunohistochemistry (IHC). Expression level was classified as tumor cells (TC) 3 (≥ 50%), TC2 (5-49%), TC1 (1-4%), or TC0 (< 1%), and as tumor-infiltrating immune cells (IC) 3 (≥ 50%), IC2 (5-49%), IC1 (1-4%), or IC0 (< 1%) for PD-L1.
FGFR1酪氨酸激酶结构域的突变或PTEN的失活与在FGFR1驱动的 …
fgfr1激酶结构域中激活的v561m突变和pten的突变失活导致pi3k / akt活性增加。 PTEN突变细胞中PTEN的异位表达使它们对FGFR抑制剂重新敏感。 用BGJ398与BEZ235 PI3K抑制剂联合治疗耐药细胞,可显示出对体外生长的累加效应,并延长了异种移植体内模型的存活时间。
肺鳞癌患者中FGFR1基因扩增和PTEN表达缺失的检测及其临床意 …
目的:纤维母细胞生长因子受体1(fibroblast growth factor receptor 1,FGFR1)基因扩增是目前肺鳞癌中最具有发展潜力药物分子靶点之一.目前,多个FGFR1抑制剂的临床试验正在进行中,如AZD4547、BGJ398、LY2874455等.但中国肺鳞癌患者中FGFR1基因扩增的发生频率及临床意义 …
Interruption of KLF5 acetylation promotes PTEN -deficient …
2024年5月23日 · CX3CR1 inhibition blocked FGFR1 activation triggered by FGF9 and sensitized PTEN-deficient prostate cancer to the AKT inhibitor capivasertib. This study reveals the role of KLF5 acetylation in reprogramming CAFs and provides a rationale for combined therapies using inhibitors of AKT and CX3CR1.
Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN …
In the present report, two unique mechanisms for resistance were identified in FGFR1-resistant cell lines, one involving an activating mutation in FGFR1 and the second mutational inactivation of PTEN, with upregulation of PI3K signaling.
FGF20-FGFR1 signaling through MAPK and PI3K controls sensory …
Background: Fibroblast Growth Factor 20 (FGF20)-FGF receptor 1 (FGFR1) signaling is essential for cochlear hair cell (HC) and supporting cell (SC) differentiation. In other organ systems, FGFR1 signals through several intracellular pathways including MAPK (ERK), PI3K, phospholipase C ɣ (PLCɣ), and p38.
- 某些结果已被删除